Show
Sort by
-
- Journal Article
- A1
- open access
Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis : a subset analysis of two phase 3 randomized trials in plaque psoriasis
-
- Journal Article
- A1
- open access
Real-life effectiveness of apremilast for the treatment of psoriasis in Belgium : results from the observational OTELO study
-
Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts : in vitro study
-
A phase III, randomized, controlled trial of apremilast in patients with psoriatic arthritis : results of the PALACE 2 trial
-
Treatment of spondyloarthritis beyond TNF-alpha blockade